A previous study showed that tilianin pretreatment improved mitochondrial energy metabolism and decreased oxidative stress through the AMPK/SIRT1/PGC-1α signaling pathway, thus attenuating myocardial ischemia/reperfusion injury [23]. The gene discussed is PPARGC1A; the disease is myocardial ischemia.